A new study – published in Nursing Research – has found that the COVID-19 pandemic significantly impacted patient safety indicators in U.S. hospitals. The study, from Penn Nursing’s Center for Health Outcomes and Policy Research (CHOPR), examined data from the National Database of Nursing Quality Indicators to assess trends in nursing-sensitive quality indicators  from 2019 to 2022. The prevention of these very distressing, uncomfortable conditions is considered to be under the nurse’s purview and directly influenced by nursing care.

A research team including Osaka University analyzed wastewater surveillance methods for accurately tracking COVID-19 infection trends. Using wastewater data from Sapporo dating from April 2021–September 2023, they explored survey conditions obtaining strong correlation between viral concentration in wastewater and infection incidence. The study identified key methods, including high-sensitivity analysis and geometric mean data processing, as essential for effective regional surveillance, providing critical insights for future public health monitoring.

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies. Their findings, including preclinical studies in mice, introduce the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, a new antibody approach for addressing how viruses like SARS-CoV-2, which causes COVID-19, evolve to evade vaccines and treatments. Details on the results were published October 23 in the journal Cell.